Corbett Keeling is pleased to announce that its client, Intrapharm Laboratories, has successfully raised debt funding in order to finance the company’s acquisition strategy.

Intrapharm Laboratories supplies both niche and branded pharmaceuticals to the NHS and international markets. Its team of professionals has many years of experience in the commercialisation of pharmaceutical products, taking them from registration to patient and thereby fostering a mutually beneficial relationship.

“Corbett Keeling's knowledge and understanding of the UK debt market and our contacts with the key decision makers enabled us to identify quickly and accurately the most appropriate source of debt funding for our client,” commented Jim Keeling, Chairman and Chief Executive of Corbett Keeling.